Sunday, September 13, 2026
ExploreSearch
Via News

financial-regulation

2 articles

U.S. Ratings Firm's Dual Role Echoes Global Conflict-of-Interest Debate

U.S. Ratings Firm's Dual Role Echoes Global Conflict-of-Interest Debate

The Oasis Group rates wealth management and estate planning vendors while selling consulting services to the same market — a structural conflict regulators worldwide have scrutinized since 2008. The firm's 2026 Peaks for Estate Planning Platforms report is widely cited in fintech circles, raising questions about independence that remain publicly unanswered. No specific incident has been identified, but analysts rate the governance risk as major severity.

LM Salvado•
Texas CEO Nate Paul Convicted of Wire Fraud in $172M Real Estate Scheme

Texas CEO Nate Paul Convicted of Wire Fraud in $172M Real Estate Scheme

Nate Paul, CEO of Austin-based World Class Capital Group, faces mandatory restitution and asset forfeiture after conviction for wire fraud involving falsified loan applications. Federal prosecutors pursue recovery of losses from commercial real estate financing fraud that exploited US banking systems. The case reflects intensified global enforcement against real estate loan fraud, with similar prosecutions rising in UK, Australia, and Canada.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com